Healthcare · Medical - Devices
Price
$5.76
Market Cap
$3.1M
Employees
10
Beta
-1.41
Avg Volume
37,018
CEO
Bradley A. Hauser
Business Description
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Business History
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-2.48
Stock Price: $5.76
EPS (Diluted): -2.32
EPS (Diluted): -2.32
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.48
Stock Price: $5.76
Total Equity: $5.90M
Shares: 72,167,570
Total Equity: $5.90M
Shares: 72,167,570
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
0.25
Market Cap: $3.13M
Total Debt: $0.00
Cash: $7.00M
EBITDA: -$17.03M
Total Debt: $0.00
Cash: $7.00M
EBITDA: -$17.03M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
-$4.2M
Market Cap: $3.13M
Total Debt: $0.00
Cash: $7.00M
Total Debt: $0.00
Cash: $7.00M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.00
Stock Price: $5.76
Revenue: $0.00
Shares: 72,167,570
Revenue: $0.00
Shares: 72,167,570
EV/Sales (Total value vs revenue — works when P/E can't)
API0.00
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
0.0%
Gross Profit: -$12,000
Revenue: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
0.0%
Operating Income: -$17.03M
Revenue: $0.00
Revenue: $0.00
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
0.0%
Net Income: -$16.72M
Revenue: $0.00
Revenue: $0.00
ROE (Profit from shareholder equity)
CALCNet Income / Total Equity
-283.5%
Net Income: -$16.72M
Total Equity: $5.90M
Total Equity: $5.90M
ROIC (Profit from all invested capital)
CALCNOPAT / Invested Capital
1,536.0%
Operating Income: -$17.03M
Tax Rate: 0.0%
Equity: $5.90M
Total Debt: $0.00
Cash: $7.00M
Tax Rate: 0.0%
Equity: $5.90M
Total Debt: $0.00
Cash: $7.00M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
4.45
Current Assets: $7.58M
Current Liabilities: $1.71M
Current Liabilities: $1.71M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $5.90M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $5.90M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 72,167,570
Shares: 72,167,570
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$0.08
Total Equity: $5.90M
Shares: 72,167,570
Shares: 72,167,570
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.17
Operating CF: -$12.28M
CapEx: -$10,000
Shares: 72,167,570
CapEx: -$10,000
Shares: 72,167,570
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $5.76
Stock Price: $5.76
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$16.72M
Net Income: -$16.72M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares AMIX against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 23, 2026 3:57pm (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 | $12,000 |
| Gross Profit | $0 | $0 | $0 | $0 | $-12,000 |
| Operating Expenses | $13.6M | $2.0M | $12.0M | $11.6M | $17.0M |
| Operating Income | -$13.6M | -$2.0M | -$12.0M | -$11.6M | -$17.0M |
| Net Income | -$13.3M | -$2.0M | -$15.4M | -$11.4M | -$16.7M |
| EBITDA | -$13.6M | -$2.0M | -$15.3M | -$11.1M | -$17.0M |
| EPS | $-0.71 | $-0.11 | $-21.10 | $-6.46 | $-2.32 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 23, 2026 3:57pm (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2.0M | $865,000 | $8.6M | $9.1M | $7.0M |
| Total Current Assets | $2.1M | $865,000 | $9.4M | $9.6M | $7.6M |
| Total Assets | $2.1M | $865,000 | $9.4M | $9.8M | $7.6M |
| Current Liabilities | $93,242 | $221,000 | $777,000 | $1.7M | $1.7M |
| Long-Term Debt | $0 | $0 | $1.0M | $0 | $0 |
| Total Liabilities | $93,242 | $221,000 | $1.8M | $1.7M | $1.7M |
| Total Equity | $2.0M | $644,000 | $7.6M | $8.1M | $5.9M |
| Retained Earnings | -$21.6M | -$23.5M | -$39.0M | -$50.4M | -$67.1M |
Cash Flow (Annual)
Last updated: Jun 23, 2026 3:57pm (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-387,307 | -$1.9M | -$6.6M | -$8.3M | -$12.3M |
| Capital Expenditure | $-3 | $-2 | $-19,000 | $-14,000 | $-10,000 |
| Free Cash Flow | $-387,310 | -$1.9M | -$6.7M | -$8.3M | -$12.3M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $2.0M | -$1.2M | $7.7M | $528,000 | -$2.1M |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 11:57am (20h ago)| Metric | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|
| Revenue |
$900,000 $900,000 – $900,000
|
$1.8M $1.8M – $1.8M
|
$11.6M $11.6M – $11.6M
|
$29.3M $29.3M – $29.3M
|
| EBITDA | $0 | $0 | $0 | $0 |
| Net Income |
$-319,600 $-319,600 – $-319,600
|
$-285,234 $-285,234 – $-285,234
|
$-202,757 $-202,757 – $-202,757
|
$-61,858 $-61,858 – $-61,858
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 23, 2026 3:57pm (3d ago)| Metric | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue Growth | — | — | — | — |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | +85.4% | -504.5% | +3.7% | -47.0% |
| Net Income Growth | +85.1% | -675.2% | +26.0% | -46.5% |
| EBITDA Growth | +85.4% | -667.1% | +27.6% | -54.1% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for AMIX — it's generated by the pipeline (
market-narrative step).
No community reviews yet for AMIX.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30